Bakula, M.; Hudolin, T.; Knezevic, N.; Zimak, Z.; Andelic, J.; Juric, I.; Gamulin, M.; Gnjidic, M.; Kastelan, Z.
Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer. Life 2024, 14, 789.
https://doi.org/10.3390/life14070789
AMA Style
Bakula M, Hudolin T, Knezevic N, Zimak Z, Andelic J, Juric I, Gamulin M, Gnjidic M, Kastelan Z.
Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer. Life. 2024; 14(7):789.
https://doi.org/10.3390/life14070789
Chicago/Turabian Style
Bakula, Mirko, Tvrtko Hudolin, Nikola Knezevic, Zoran Zimak, Jerko Andelic, Ilija Juric, Marija Gamulin, Milena Gnjidic, and Zeljko Kastelan.
2024. "Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer" Life 14, no. 7: 789.
https://doi.org/10.3390/life14070789
APA Style
Bakula, M., Hudolin, T., Knezevic, N., Zimak, Z., Andelic, J., Juric, I., Gamulin, M., Gnjidic, M., & Kastelan, Z.
(2024). Intravesical Gemcitabine and Docetaxel Therapy for BCG-Naïve Patients: A Promising Approach to Non-Muscle Invasive Bladder Cancer. Life, 14(7), 789.
https://doi.org/10.3390/life14070789
